PONTI

This brand name is authorized in Mexico.

Active ingredients

The drug PONTI contains one active pharmaceutical ingredient (API):

`1`	Tetracaine UNII `5NF5D4OPCI` - TETRACAINE HYDROCHLORIDE
	Tetracaine is a local anaesthetic and is believed to act by blocking nerve conduction mainly by inhibiting sodium ion flux across the axon membrane.
	Read more about Tetracaine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01HA03	Tetracaine	S Sensory organs → S01 Ophthalmologicals → S01H Local anesthetics → S01HA Local anesthetics
Discover more medicines within S01HA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	40714

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.